Stockholders' Equity |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity | Note 5 – Stockholders' Equity
The Company is authorized to issue shares of common stock, par value $ per share. As of March 31, 2026, there were shares of common stock issued and outstanding. As of December 31, 2025, there were shares issued and outstanding.
Set forth below is information regarding the issuance and sales of securities without registration through March 31, 2026. No such sales involved the use of an underwriter, no advertising or public solicitation was involved, the securities bear a restrictive legend, and no commissions were paid in connection with the sale of any securities.
Since January 1, 2025 through March 31, 2026, the Company issued an aggregate of shares of common stock, consisting of shares issued for services, shares issued for an asset, and shares issued for cash. The related amounts recorded were as follows: shares issued for services — common stock of $9,400 and additional paid-in capital of $754,795; shares issued for asset acquisition — common stock of $174 and additional paid-in capital of $295,393; and shares issued for cash — common stock of $1,947 and additional paid-in capital of $156,991. During the three months ended March 31, 2026, the Company issued shares for cash proceeds of $.
On February 5, 2022, the Company issued shares of common stock to Andrew Read at $ per share for $2,300. On December 28, 2023, the Company issued shares of common stock to Andrew Read at $ per share for services. The issuances were exempt from registration by reason of Section 4(a)(2) of the Securities Act as transactions not involving a public offering.
The Company issued shares in a Regulation D, Rule 506 offering filed with the SEC on March 11, 2022, at an offering price of $0.01 per share, resulting in total proceeds of $69,400. None of the investors were affiliated with any of the Company’s directors, officers, promoters, or beneficial owners of 10% or more of its securities.
As of March 31, 2026, the Company had shares of common stock issued and outstanding.
Warrants
During 2025, the Company issued warrants to purchase an aggregate of 946,667 shares of common stock to the Beling Family Trust. During the three months ended March 31, 2026, the Company issued additional warrants to purchase an aggregate of 1,000,000 shares of common stock to the Beling Family Trust.
A summary of warrant activity for the three months ended March 31, 2026 is as follows:
As of March 31, 2026, warrants were outstanding and exercisable, with a weighted average exercise price of $0.06 per share.
The following table summarizes warrants outstanding at March 31, 2026:
Weighted Average term remaining:
For the current period issuances:
1,000,000 warrants issued during the quarter ended March 31, 2026 had a weighted-average remaining contractual term of approximately years.
For the total warrants outstanding at March 31, 2026:
1,946,667 warrants outstanding had a weighted-average remaining contractual term of approximately years.
We have never utilized an underwriter for an offering of our securities. Other than the securities mentioned above and the common stock issuances described below, we have not issued or sold any other securities.
During the three months ended March 31, 2026, the Company issued shares of common stock to the Beling Family Trust for aggregate proceeds of $50,000 pursuant to subscription agreements.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||